Skip to main content
Premium Trial:

Request an Annual Quote

Bruker BioSciences Implements Post-Merger Consolidation

NEW YORK, Oct. 21 (GenomeWeb News) - Bruker BioSciences, which formed on July 1 through the merger of Bruker Daltonics and Bruker AXS, said yesterday that it is embarking upon a cost-cutting consolidation strategy that goes "beyond the original merger plan."

The restructuring, which has already been partially implemented and is expected to be finalized in the second quarter of 2004, includes the consolidation of the Bruker AXS x-ray systems production in Madison, Wis. The company will also outsource or transfer to its other production centers the manufacturing of certain technologies previously manufactured by Bruker-Nonius, a subsidiary of Bruker AXS located in Delft, The Netherlands. This business will now focus on applications for life science x-ray crystallography and structural proteomics, as well as on marketing and customer support, the company said. In addition, the Bruker Daltonics business will phase out manufacturing of substance detection products at its Faellanden, Switzerland, site by the end of the second quarter of 2004.

Bruker BioSciences said the consolidation plan should improve its operating performance by $2.5 million to $3.0 million annually pre-tax, beginning in the third quarter of 2004.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.